These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 15619396)

  • 1. Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Yang NI
    Am J Cardiol; 2005 Jan; 95(1):84-7. PubMed ID: 15619396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug therapy in angina pectoris].
    Follath F
    Praxis (Bern 1994); 1995 Oct; 84(42):1186-9. PubMed ID: 7481332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical evaluation of the efficacy of Isoket in patients with vasospastic stenocardia].
    Bobrov VA; Simorot VN
    Ter Arkh; 1992; 64(9):39-42. PubMed ID: 1481153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disease activities and serum C-reactive protein levels in patients with vasospastic angina pectoris].
    Katayama N; Nakao K; Horiuchi K; Kasanuki H; Honda T
    J Cardiol; 2005 Aug; 46(2):63-70. PubMed ID: 16127895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of benidipine for vasospastic angina pectoris.
    Suzuki H; Yokoyama K; Akimoto Y; Daida H
    Arzneimittelforschung; 2007; 57(1):20-5. PubMed ID: 17341005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease.
    Hung MJ; Cherng WJ; Yang NI; Cheng CW; Li LF
    Am J Cardiol; 2005 Dec; 96(11):1484-90. PubMed ID: 16310426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transcutaneous application of nitroglycerin and isosorbide dinitrate versus placebo: effect in myocardial ischemia].
    Gloor HO; Angehrn W; Steinbrunn W
    Schweiz Med Wochenschr; 1985 Mar; 115(12):412-7. PubMed ID: 3922052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of calcium antagonists on coronary artery spasm and prevention of restenosis after angioplasty].
    Kocurek A; Piwowarska W
    Przegl Lek; 1997; 54(1):37-42. PubMed ID: 9190633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is optimal drug therapy in angina pectoris?
    Frankl WS; Brest AN
    Cardiovasc Clin; 1983; 13(1):209-20. PubMed ID: 6129060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary spastic angina refractory to optimal medical therapy treated by angioplasty and stenting. A case report and review of literature].
    Hajlaoui N; Tarragano F; Raisky P; Beaufils P; Henry P
    Ann Cardiol Angeiol (Paris); 2010 Apr; 59(2):103-6. PubMed ID: 19007921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivessel coronary artery spasm refractory to intensive medical treatment.
    Asano T; Kobayashi Y; Ohno M; Nakayama T; Kuroda N; Komuro I
    Angiology; 2007; 58(5):636-9. PubMed ID: 17906282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina: Aomori coronary spastic angina study.
    Higuma T; Oikawa K; Kato T; Mori Y; Kudo T; Yamamoto T; Hoshi Y; Kameda K; Suto N; Fujita N; Inokubo Y; Konta A; Osanai T; Okumura K
    J Cardiol; 2010 Nov; 56(3):354-60. PubMed ID: 20884177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic stable angina pectoris. Strategies for effective drug therapy.
    Thadani U; Chohan A
    Postgrad Med; 1995 Dec; 98(6):175-6, 179-83, 187-8. PubMed ID: 7501578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary vasospasm at the site of myocardial bridge--report of two cases.
    Kodama K; Morioka N; Hara Y; Shigematsu Y; Hamada M; Hiwada K
    Angiology; 1998 Aug; 49(8):659-63. PubMed ID: 9717898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the coronary diameter and occurrence of vasospastic angina in patients with normal coronary arteries.
    Kurimoto T; Karakawa M; Baden M; Matsuura T; Shimada T; Sugiura T; Inada M
    Jpn Circ J; 1989 Jul; 53(7):747-55. PubMed ID: 2810686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease.
    Hung MJ; Cheng CW; Yang NI; Hung MY; Cherng WJ
    Int J Cardiol; 2007 Apr; 117(1):37-44. PubMed ID: 16844245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical characteristics and prognosis in Taiwanese patients with coronary vasospastic angina pectoris without significant fixed coronary artery disease versus patients with significant fixed coronary artery disease and either stable angina pectoris or acute coronary syndromes.
    Hung MJ; Hung MY; Cheng CW; Yang NI; Cherng WJ
    Am J Med Sci; 2007 Sep; 334(3):160-7. PubMed ID: 17873528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient management of coronary artery disease.
    Bingle JF; Mayhew HE
    Am Fam Physician; 1987 Jul; 36(1):191-200. PubMed ID: 2886033
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary artery vasoconstriction and its treatment with calcium channel blockers.
    Shapiro W
    Ala J Med Sci; 1985 Jul; 22(3):271-4. PubMed ID: 4025717
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.